Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma

NCT04977375 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

DRUG: Pembrolizumab
RADIATION: Stereotactic Radiation Therapy
PROCEDURE: Surgical Resection

Sponsor

Chirag G. Patil

Collaborators

[object Object]
[object Object]